PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 1, 2017CONTINUUM Lifelong Learning in Neurology641 citations

Stroke Epidemiology and Risk Factor Management

View Full Paper
AGAmy GuzikCBCheryl Bushnell

Key Points

  • To review current trends in stroke epidemiology and summarize evidence-based management strategies for major modifiable and emerging stroke risk factors.
  • Synthesis of published clinical literature, epidemiological data, and prevention guidelines for primary and secondary stroke prevention.
  • Evaluation of pharmacological therapies, lifestyle modifications, and emerging clinical risk factors illustrated through a case-based approach.
  • Declines in stroke incidence and mortality over the past decade reflect increased clinical utilization of statins and antihypertensive therapies.
  • Effective secondary stroke prevention requires a multifactorial strategy combining antiplatelet agents, blood pressure control that minimizes blood pressure variability, and screening for emerging risks such as obstructive sleep apnea and elevated lipoprotein(a).

Abstract

PURPOSE OF REVIEW: Death from stroke has decreased over the past decade, with stroke now the fifth leading cause of death in the United States. In addition, the incidence of new and recurrent stroke is declining, likely because of the increased use of specific prevention medications, such as statins and antihypertensives. Despite these positive trends in incidence and mortality, many strokes remain preventable. The major modifiable risk factors are hypertension, diabetes mellitus, tobacco smoking, and hyperlipidemia, as well as lifestyle factors, such as obesity, poor diet/nutrition, and physical inactivity. This article reviews the current recommendations for the management of each of these modifiable risk factors. RECENT FINDINGS: It has been documented that some blood pressure medications may increase variability of blood pressure and ultimately increase the risk for stroke. Stroke prevention typically includes antiplatelet therapy (unless an indication for anticoagulation exists), so the most recent evidence supporting use of these drugs is reviewed. In addition, emerging risk factors, such as obstructive sleep apnea, electronic cigarettes, and elevated lipoprotein (a), are discussed. SUMMARY: Overall, secondary stroke prevention includes a multifactorial approach. This article incorporates evidence from guidelines and published studies and uses an illustrative case study throughout the article to provide examples of secondary prevention management of stroke risk factors.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Guzik et al. (2017) studied this question.

synapsesocial.com/papers/69fd8194ea4a61241c5d266chttps://doi.org/10.1212/con.0000000000000416
Ask AI
Helpful
Bookmark
Share
View Full Paper